Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GTX Inc (NASDAQ:GTXI)

8.66
Delayed Data
As of 12:16pm ET
 -0.1108 / -1.26%
Today’s Change
2.73
Today|||52-Week Range
9.90
+64.00%
Year-to-Date

Today’s Trading

Previous close8.77
Today’s open9.30
Day’s range8.52 - 9.30
Volume18,454
Average volume (3 months)172,639
Market cap$140.8M
Dividend yield--
Data as of 12:16pm ET, 09/26/2017

Growth & Valuation

Earnings growth (last year)+18.67%
Earnings growth (this year)+4.92%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book7.02

Competitors

 Today’s
change
Today’s
% change
RGLSRegulus Therapeutics...-0.03-1.84%
GLMDGalmed Pharmaceutica...-0.35-3.83%
ZFGNZafgen Inc0.000.00%
MEIPMEI Pharma Inc+0.09+3.35%
Data as of 12:29pm ET, 09/26/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$17.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Marc Steven Hanover
Principal Financial &
Accounting Officer
Jason T. Shackelford
Corporate headquarters
Memphis, Tennessee

Forecasts